Dr. Reddy’s Laboratories informs about press release

14 Jun 2022 Evaluate

Dr. Reddy’s Laboratories enclosed a Press Release on ‘Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1287.20 -31.70 (-2.40%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×